Kenneth Anderson
Dana-Farber Cancer Institute

Last Updated On 8/22/2021 1:01:59 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
Company: OncoPep
Recipient: You
Company: C4 Therapeutics
Recipient: You
Company: Mana Therapeutics
Recipient: You
Company: Raqia Therapeutics
Recipient: You
Company: NextRNA
Recipient: You
Company: starton therapeutics
Recipient: You

Stock and Other Ownership Interests
Company: C4 Therapeutics
Recipient: You
Company: OncoPep
Recipient: You
Company: Mana Therapeutics
Recipient: You
Company: Raqia Therapeutics
Recipient: You
Company: NextRNA
Recipient: You
Company: STARTON Therapeutics
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Millennium
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Sanofi
Recipient: You
Company: Precision Biosciences
Recipient: You
Company: Pfizer
Recipient: You
Company: amgen
Recipient: You
Company: AstraZeneca
Recipient: You
Company: oncopeptides
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
No Relationships to Disclose

Patents, Royalties, Other Intellectual Property
Please describe: C4 Therapeutics
Recipient: You
Please describe: Oncopep
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered